**Beauty Health Co. Reports Fiscal Year 2025 Results**

The Beauty Health Company (SKIN) reported its financial results for the fiscal year ended December 31, 2025, with net sales totaling $300.8 million, a 10% decrease compared to $334.3 million in 2024. This decline was primarily attributed to a decrease in Delivery Systems net sales, which fell by 29.8% to $88.1 million, while Consumables net sales increased slightly by 1.8% to $212.7 million. The company experienced a loss from operations of $20.8 million, a significant improvement compared to the $67.8 million loss in the previous fiscal year.

Despite the decrease in overall revenue, Beauty Health Co. saw a notable improvement in its gross margin, which increased to 65.3% in 2025 from 54.5% in 2024. This was primarily due to lower inventory-related charges and a favorable shift in product mix towards Consumables, which have higher margins. Operating expenses also decreased by 13.2% to $217.2 million, driven by lower personnel-related expenses and reduced marketing spend. The company reported a net loss of $9.5 million, or $0.08 per share, compared to a net loss of $29.1 million, or $0.23 per share, in the prior year.

Operationally, Beauty Health Co. focused on several strategic initiatives, including salesforce excellence, marketing discipline, and focused innovation. The company transitioned to a value-based selling approach and invested in commercial analytics to improve activation, utilization, and retention across its installed base. Marketing efforts were directed towards generating consumer demand and reinforcing the clinical credibility of the Hydrafacial platform. Innovation efforts prioritized clinically supported technologies and products that expand the capabilities of the platform and improve provider economics. The company also continued to expand its product development pipeline, focusing on boosters and the MyBeautyHealth mobile application, which rewards consumers for investing in their skin health.

Beauty Health Co. employed 613 individuals as of December 31, 2025, with 67% based in the United States. The company emphasized talent attraction and development through targeted marketing practices and investments in career development programs. Diversity and inclusion initiatives were also prioritized, with 53% of the U.S. workforce identifying as minorities. Looking ahead, the company aims to establish itself as a leader in medical aesthetics by delivering an integrated ecosystem of solutions that combine devices, consumables, clinical credibility, and brand strength. However, the company acknowledges several risk factors that could affect its future performance, including increased competition, dependence on the commercial success of Delivery Systems, and potential disruptions in its operations.

About Beauty Health Co

The Beauty Health Company designs, manufactures, and markets esthetic medical devices and consumables focused on skin and scalp health. Its flagship Hydrafacial brand offers patented hydradermabrasion treatments via proprietary Delivery Systems and consumables, supported by complementary brands SkinStylus (microneedling) and Keravive (scalp care). Serving professional medical providers and estheticians globally, the company employs a razor-and-blades business model, leveraging a community-driven platform to deliver personalized, non-invasive beauty health experiences.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-K Filings

A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.

Key points about the 10-K:

  • Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
  • Content: It includes:
    • Detailed financial statements audited by an independent accounting firm
    • Management's Discussion and Analysis (MD&A) of financial condition and results
    • Description of the company's business, properties, and legal proceedings
    • Risk factors and market risks
    • Executive compensation and corporate governance information
  • Importance: Considered the most comprehensive and important document a public company files with the SEC.
  • Length: Often exceeds 100 pages due to its extensive and detailed nature.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.